Myung‐Ju Ahn

Papers

Total Citations

H-Index

About

Myung‐Ju Ahn is a leading oncologist whose research has profoundly shaped the understanding and treatment of lung cancer, particularly within the Korean population. Her major contributions center on the epidemiological and clinical characterization of lung cancer in Korea, providing critical insights into regional variations in disease presentation, risk factors, and treatment outcomes. Her seminal work, "Lung Cancer in Korea" (2021), has garnered 11 citations, serving as a foundational reference for clinicians and researchers seeking to tailor therapies to specific genetic and environmental contexts. Beyond this landmark paper, Ahn's broader portfolio includes pivotal studies on targeted therapies and immunotherapies, advancing personalized medicine for non-small cell lung cancer. Her research has directly influenced national treatment guidelines and improved survival rates for patients. With a career dedicated to bridging global oncology standards with local needs, Ahn remains a respected figure in translational cancer research, mentoring the next generation of specialists and driving collaborative efforts to reduce the burden of lung cancer in Asia.